PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling

Colorectal cancer (CRC) remains the third most commonly diagnosed cancer, ranking second among the most common causes of cancer-related mortality. Immune checkpoint therapy has recently been shown to have great potential. However, only some patients respond to immune checkpoint blockade, indicating...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, JunLi, Ge, XiaoXiao, Zhao, Wei, Xue, Liqiong, Dai, Congqi, Lin, Fengjuan, Peng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874988/
https://www.ncbi.nlm.nih.gov/pubmed/31781676
http://dx.doi.org/10.1155/2019/3690561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874988/
https://www.ncbi.nlm.nih.gov/pubmed/31781676
http://dx.doi.org/10.1155/2019/3690561

Ejemplares similares